Nicholas Adams - Bioquell plc Insider

BIQLF -- USA Stock  

USD 6.28  0.00  0.00%

Mr. Nicholas M. T. Adams is Chief Executive, Executive Director of Bioquell PLC. He Joined the Board in May 1997 and was appointed Chief Executive in May 1998. Previously he was a Director of Corporationrationrate Finance at Barings, an investment bank, having spent nine years in Barings Corporationrationrate Finance Department both in the UK and continental Europe. He read chemistry at Durham University.
  Director Since 1998      
44 1264 835 835

Management Efficiency

The company has return on total asset (ROA) of 5.58 % which means that it generated profit of $5.58 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.64 % meaning that it generated $10.64 on every $100 dollars invested by stockholders.

Similar Executives

Entity Summary

Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and traded on OTC Market. It employs 220 people.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 220 people.

Bioquell plc Leadership Team

Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director
Simon Constantine, Independent Non-Executive Director

Stock Performance Indicators

Did you try this?

Run Portfolio Center Now

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Portfolio Center

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Bioquell plc and Bristol Myers Squibb. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.